代谢障碍在动脉样硬化发展中的作用
Alexander V Blagov1, Alexey V Churov2, Alexander L Golovyuk3
1Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia. al.blagov2014@gmail.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|October 9, 2024
概括
动脉样硬化是心血管疾病的关键驱动因素,涉及内皮功能障碍和代谢障碍. 了解这些阶段和代谢目标为预防疾病进展提供了新的治疗途径.
科学领域:
- 心血管科学 心血管科学
- 代谢性疾病研究研究
- 病理学 病理学 病理学
背景情况:
- 动脉样硬化是心血管疾病 (CVD) 的主要危险因素,是全球主要的死亡原因.
- 疾病过程包括内皮激活,脂质积累,纤维状斑块形成和化,导致血管收缩和炎症.
研究的目的:
- 审查动脉样硬化发展的多面阶段,从最初的内皮功能障碍到斑块破裂.
- 检查新陈代谢失调的作用,包括脂质,葡萄糖和氨基酸代谢,在动脉样硬化病原体中的作用.
- 提出针对新陈代谢途径的治疗策略,以管理动脉样硬化.
主要方法:
- 文献综述专注于动脉样硬化的病理阶段.
- 分析脂质,葡萄糖和氨基酸通路中的代谢干扰.
- 在代谢途径内评估治疗点,包括酶和运输蛋白.
主要成果:
- 内皮功能障碍启动了一系列导致脂质积累,斑块形成和炎症的过程.
- 脂质,葡萄糖和氨基酸代谢的破坏是动脉样硬化发展的组成部分.
- 调节涉及脂质代谢的特定酶和运输蛋白质显示了治疗潜力.
结论:
- 对动脉样硬化病原体的全面理解需要详细考虑代谢中断.
- 针对代谢途径,特别是脂质代谢,提供了有希望的治疗策略,以预防疾病的进展和管理患者的症状.
相关概念视频
Atherosclerosis I: Introduction
2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Overview of Lipid Metabolism
1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Overview of Carbohydrate Metabolism
764
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
764
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2


